Drug Resistant Epilepsy – Society of Cannabis Clinicians https://www.cannabisclinicians.org Educating Healthcare Professionals about the Medical Use of Cannabis Thu, 19 Oct 2023 00:26:27 +0000 en-US hourly 1 https://wordpress.org/?v=6.2.3 https://www.cannabisclinicians.org/wp-content/uploads/2020/07/cropped-scc-flavicon-32x32.png Drug Resistant Epilepsy – Society of Cannabis Clinicians https://www.cannabisclinicians.org 32 32 Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy https://www.cannabisclinicians.org/2023/10/18/updated-clinical-recommendations-for-the-management-of-tuberous-sclerosis-complex-associated-epilepsy/ Thu, 19 Oct 2023 00:26:27 +0000 https://www.cannabisclinicians.org/?p=29468 Children with tuberous sclerosis complex (TSC), may experience a variety of seizure types in the first year of life, most often focal seizure sand epileptic spasms. Drug resistance is seen early in many patients, and the management of TSC associated epilepsy remain a major challenge for clinicians. In 2018 clinical recommendations for the management of TSC associated epilepsy were published by a panel of European experts. In the last five years considerable progress has been made in understanding the neurobiology of epileptogenesis and three interventional randomized controlled trials have changed the therapeutic approach for the management of TSC associated epilepsy. Pre-symptomatic treatment with vigabatrin may delay seizure onset, may reduce seizure severity and reduce the risk of epileptic encephalopathy.

The post Updated clinical recommendations for the management of tuberous sclerosis complex associated epilepsy appeared first on Society of Cannabis Clinicians.

]]> Real-World evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex https://www.cannabisclinicians.org/2023/09/20/real-world-evidence-on-the-use-of-cannabidiol-for-the-treatment-of-drug-resistant-epilepsy-not-related-to-lennox-gastaut-syndrome-dravet-syndrome-or-tuberous-sclerosis-complex/ Thu, 21 Sep 2023 00:08:12 +0000 https://www.cannabisclinicians.org/?p=29236 Highly purified cannabidiol (CBD) has a broad spectrum of action and could be useful for the treatment of drug resistant epilepsy regardless of etiology or syndrome. Multicenter retrospective study that evaluated the efficacy and safety of CBD for the treatment of drug resistant epilepsy of different etiologies in patients >2 years of age.

The post Real-World evidence on the use of cannabidiol for the treatment of drug resistant epilepsy not related to Lennox-Gastaut syndrome, Dravet syndrome or Tuberous Sclerosis Complex appeared first on Society of Cannabis Clinicians.

]]> Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center. https://www.cannabisclinicians.org/2018/03/01/efficacy-of-artisanal-preparations-of-cannabidiol-for-the-treatment-of-epilepsy-practical-experiences-in-a-tertiary-medical-center/ Thu, 01 Mar 2018 23:14:05 +0000 https://www.cannabisclinicians.org/?p=15414 Authors: Giulia S. Porcaria, Cary Fub, Emily D. Doll, Emma G. Carter, Robert P. Carson
Epilepsy & Behavior, March 2018
---
Medically refractory epilepsy continues to be a challenge worldwide, and despite an increasing number of medical therapies, approximately 1 in 3 patients continues to have seizures. Cannabidiol (CBD), one of many constituents of the Cannabis sativa or marijuana plant, has rece...

The post Efficacy of artisanal preparations of cannabidiol for the treatment of epilepsy: Practical experiences in a tertiary medical center. appeared first on Society of Cannabis Clinicians.

]]> Cannabinoids in treatment-resistant epilepsy: A review. https://www.cannabisclinicians.org/2017/05/01/cannabinoids-in-treatment-resistant-epilepsy-a-review/ Mon, 01 May 2017 22:53:16 +0000 https://www.cannabisclinicians.org/?p=15426 Authors: Brooke K. O'Connell, David Gloss, Orrin Devinsky
Epilepsy & Behavior, May 2017
---
Treatment-resistant epilepsy (TRE) affects 30% of epilepsy patients and is associated with severe morbidity and increased mortality. Cannabis-based therapies have been used to treat epilepsy for millennia, but only in the last few years have we begun to collect data from adequ...

The post Cannabinoids in treatment-resistant epilepsy: A review. appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex. https://www.cannabisclinicians.org/2016/10/01/cannabidiol-as-a-new-treatment-for-drug-resistant-epilepsy-in-tuberous-sclerosis-complex/ Sat, 01 Oct 2016 12:27:43 +0000 https://www.cannabisclinicians.org/?p=15430 Authors: Evan J. Hess, Kirsten A. Moody, Alexandra L. Geffrey, Sarah F. Pollack, et al
Epilepsia, October 2016
---
OBJECTIVE: Tuberous sclerosis complex (TSC) is an autosomal-dominant genetic disorder with highly variable expression. The most common neurologic manifestation of TSC is epilepsy, which affects approximately 85% of patients, 63% of whom develop treatment-resistant epilepsy. He...

The post Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex. appeared first on Society of Cannabis Clinicians.

]]> Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol. https://www.cannabisclinicians.org/2016/09/30/%ce%b49-thc-intoxication-by-cannabidiol-enriched-cannabis-extract-in-two-children-with-refractory-epilepsy-full-remission-after-switching-to-purified-cannabidiol/ Fri, 30 Sep 2016 12:39:18 +0000 https://www.cannabisclinicians.org/?p=15433 Authors: José A. S. Crippa, Ana C. S. Crippa, Jaime E. C. Hallak, Rocio Martín-Santos, Antonio W. Zuardi
Frontiers in Pharmacology, 30 September 2016
---
Animal studies and preliminary clinical trials have shown that cannabidiol (CBD)-enriched extracts may have beneficial effects for children with treatment-resistant epilepsy. However, these compounds are not yet registered as medicines by regulatory agencies. We describe the c...

The post Δ9-THC Intoxication by Cannabidiol-Enriched Cannabis Extract in Two Children with Refractory Epilepsy: Full Remission after Switching to Purified Cannabidiol. appeared first on Society of Cannabis Clinicians.

]]> Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. https://www.cannabisclinicians.org/2016/03/01/cannabidiol-in-patients-with-treatment-resistant-epilepsy-an-open-label-interventional-trial/ Wed, 02 Mar 2016 01:56:30 +0000 https://www.cannabisclinicians.org/?p=15428 Authors: Orrin Devinsky, Eric Marsh, Daniel Friedman, Elizabeth Thiele, Linda Laux, et al
The Lancet Neurology, March 2016
---
BACKGROUND: Almost a third of patients with epilepsy have a treatment-resistant form, which is associated with severe morbidity and increased mortality. Cannabis-based treatments for epilepsy have generated much interest, but scientific data are scarce. We aimed to establish w...

The post Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial. appeared first on Society of Cannabis Clinicians.

]]> Medicinal marijuana for epilepsy: a case series study. https://www.cannabisclinicians.org/2014/11/01/medicinal-marijuana-for-epilepsy-a-case-series-study/ Sat, 01 Nov 2014 13:10:13 +0000 https://www.cannabisclinicians.org/?p=15443 Authors: Lady Diana Ladino, Lizbeth Hernández-Ronquillo, José Francisco Téllez-Zenteno
Canadian Journal of Neurological Sciences, November 2014
---
OBJECTIVE: To describe the social, clinical and use-patterns characteristics of medicinal marijuana use among patients with epilepsy (PWEs). METHODS: Eighteen PWEs with prescriptions for medicinal marijuana from a Canadian adult-epilepsy clinic were included in this study. RES...

The post Medicinal marijuana for epilepsy: a case series study. appeared first on Society of Cannabis Clinicians.

]]>